Wyeth BMP-2 Should Be Limited To “Problem” Fractures – Panel
This article was originally published in The Gray Sheet
Executive Summary
Wyeth's InductOs recombinant human bone morphogenic protein-2 indications for use should be limited to "problem" fractures, according to FDA's Orthopaedic and Rehabilitation Devices Panel